Immunogenicity of the BA.1 and BA.4/BA.5 Severe Acute Respiratory Syndrome Coronavirus 2 Bivalent Boosts: Preliminary Results From the COVAIL Randomized Clinical Trial.
- Resource Type
- Article
- Source
Clinical Infectious Diseases . 8/15/2023, Vol. 77 Issue 4, p560-564. 5p.- Subject
- *
IMMUNOGLOBULIN analysis
*CONFIDENCE intervals
*COVID-19 vaccines
*CORONAVIRUS spike protein
*CHRONIC diseases
*CHEMILUMINESCENCE assay
*VACCINE immunogenicity
*VACCINE effectiveness
*ANTIBODY formation
*RANDOMIZED controlled trials
*MESSENGER RNA
*DESCRIPTIVE statistics
*RESEARCH funding
*STATISTICAL sampling
*POLYMERASE chain reaction - Language
- ISSN
- 1058-4838